Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Is Life Science Tools Firm NanoString Stock Trading Lower Today?

Published 05/02/2024, 13:30
Updated 05/02/2024, 14:40
© Reuters.  Why Is Life Science Tools Firm NanoString Stock Trading Lower Today?

Benzinga - by Vandana Singh, Benzinga Editor.

On Monday, NanoString Technologies Inc (NASDAQ:NSTG) voluntarily initiated a Chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware.

Coincident with this proceeding, NanoString is exploring strategic alternatives, including the potential sale of the company or product lines.

“The unexpected outcome of the November GeoMx patent litigation trial in Delaware and the unusually large magnitude of the damages awarded by the jury have forced us to take proactive steps to protect our stakeholders, customers, and employees,” said Brad Gray, President and CEO of NanoString.

NanoString is currently the primary target of an extensive litigation campaign conducted by 10x Genomics Inc (NASDAQ:TXG).

Since May 2021, 10x has brought multiple infringement lawsuits against NanoString in the U.S. and the European Union concerning NanoString’s GeoMx Digital Spatial Profiler (DSP) and CosMx Spatial Molecular Imager (SMI) product lines.

The company has faced unfavorable initial rulings that have impacted its business trajectory and financial position.

In November, a jury in the U.S. District Court for the District of Delaware reached a unanimous verdict favoring 10x Genomics in the patent infringement suit 10x filed against NanoString’s GeoMx products.

In awarding over $31 million in damages, the jury found that NanoString’s GeoMx Digital Spatial Profiler and associated instruments, reagents, and services for RNA and protein detection willfully infringe all seven asserted patents owned by Prognosys and exclusively licensed to 10x Genomics.

NanoString has reached an agreement in principle with certain of incumbent lenders to provide with at least $40 million in new capital in the form of debtor-in-possession financing.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Upon approval of the Bankruptcy Court, this financing facility is expected to provide sufficient liquidity to operate the company’s business during the pendency of the cases.

NanoString will continue to serve researchers across its installed base of over 1,500 nCounter, GeoMx DSP, and CosMx SMI platforms.

Price Action: NSTG shares are down 59.43% at $0.1899 during the premarket session on the last check Monday.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.